Zhongchao Inc. current report, Q1 FY2021

Zhongchao Inc. Form 6-K Summary

Business Context and Reporting Period

Zhongchao Inc., a foreign private issuer that files Form 20-F, furnished this Form 6-K for January 2021. The filing was signed and submitted on January 13, 2021.

The filing reports that the Company co-sponsored the National Annual Conference for Standardized Liver Cancer Diagnosis and Treatment with the China Association of Health Promotion and Education and the Chinese Society of Liver Cancer.

Financial and Operating Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other quantitative financial metrics.

Material Changes Versus Prior Period

No financial or operating comparison with a prior period is provided. The disclosed event is the Company’s co-sponsorship of the liver cancer diagnosis and treatment conference.

Guidance, Outlook, Risks, and Unusual Items

No financial guidance, outlook, management forecast, material risk update, contingency, or unusual accounting item is disclosed in the provided filing text.

The filing includes a standard securities-law disclaimer stating that it is not an offer to sell or solicitation to buy securities.

Important Facts to Verify

  • Review Exhibit 99.1 for the full January 13, 2021 press release and additional details regarding the conference.
  • Verify whether the conference sponsorship generated any commercial, partnership, or financial impact; the filing does not quantify one.
  • Consult the Company’s annual report or other filings for financial results, liquidity, debt, and risk disclosures.